The History and Evolution of Pulmonary Function Testing Methods and Interpretation.

Saved in:
Bibliographic Details
Title: The History and Evolution of Pulmonary Function Testing Methods and Interpretation.
Authors: Hallstrand TS; Division of Pulmonary, Critical Care and Sleep Medicine, The Center for Lung Biology, University of Washington, S-381 Center for Lung Biology, 850 Republican Street, Seattle, WA 98109-4714, USA., Kaminsky DA; Division of Pulmonary and Critical Care, University of Vermont College of Medicine, Burlington, VT 05405, USA. Electronic address: david.kaminsky@med.uvm.edu.
Source: Clinics in chest medicine [Clin Chest Med] 2025 Sep; Vol. 46 (3), pp. 393-400. Date of Electronic Publication: 2025 May 23.
Publication Type: Journal Article; Review; Historical Article
Language: English
Journal Info: Publisher: Elsevier Health Sciences Division Country of Publication: United States NLM ID: 7907612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8216 (Electronic) Linking ISSN: 02725231 NLM ISO Abbreviation: Clin Chest Med Subsets: MEDLINE
Imprint Name(s): Publication: <2005->: Philadelphia : Elsevier Health Sciences Division
Original Publication: Philadelphia, Saunders.
MeSH Terms: Respiratory Function Tests*/history , Respiratory Function Tests*/methods , Lung Diseases*/diagnosis , Lung Diseases*/physiopathology, Humans ; History, 20th Century ; History, 21st Century ; History, 19th Century
Abstract: Competing Interests: Disclosure T.S. Hallstrand: research funding support from NIH, consulting fees from AstraZeneca. D.A. Kaminsky: research funding support from National Institutes of Health, United States, American Lung Association, United States; speaking fees from MGC Diagnostics, Inc and Vitalograph, Inc; royalties from UptoDate, Inc and Elsevier, Inc.
The use of modern diagnostic equipment to measure pulmonary function has reached a substantial level of maturity after many decades of evolution. The ability to differentiate a normal result from a measurement that is potentially indicative of disease requires the use of normal reference values that have similarly become increasingly robust with larger and more diverse populations. The use of reference equations should carefully consider the individual being tested in relation to the reference population and a detailed understanding of the sources of variation related to geographic, socioeconomic, environmental and genetic factors.
(Copyright © 2025 Elsevier Inc. All rights reserved.)
Contributed Indexing: Keywords: Ethnicity; Global lung initiative; History; Pulmonary function; Race; Reference equation; Socioeconomic status
Entry Date(s): Date Created: 20250806 Date Completed: 20250806 Latest Revision: 20250807
Update Code: 20250808
DOI: 10.1016/j.ccm.2025.04.015
PMID: 40769587
Database: MEDLINE
Description
Abstract:Competing Interests: Disclosure T.S. Hallstrand: research funding support from NIH, consulting fees from AstraZeneca. D.A. Kaminsky: research funding support from National Institutes of Health, United States, American Lung Association, United States; speaking fees from MGC Diagnostics, Inc and Vitalograph, Inc; royalties from UptoDate, Inc and Elsevier, Inc.<br />The use of modern diagnostic equipment to measure pulmonary function has reached a substantial level of maturity after many decades of evolution. The ability to differentiate a normal result from a measurement that is potentially indicative of disease requires the use of normal reference values that have similarly become increasingly robust with larger and more diverse populations. The use of reference equations should carefully consider the individual being tested in relation to the reference population and a detailed understanding of the sources of variation related to geographic, socioeconomic, environmental and genetic factors.<br /> (Copyright © 2025 Elsevier Inc. All rights reserved.)
ISSN:1557-8216
DOI:10.1016/j.ccm.2025.04.015